About this study
This study is a 9-year natural history study for patients with Angelman syndrome in Belgium (a genetic neurodevelopmental disorder, affecting 500,000 individuals in the world). It includes a 3-year recruitment phase, a 5 year follow-up and a year to analyze the collected data. The investigators plan to include 30 patients with a semi-annual follow-up for 4 years.
The investigators will collect relevant retrospective and prospective data using age-standardized scales and questionnaires for functional motor assessments and global developmental assessment.
Study locations
Belgium
Liège
Liège (1)
- CHR Citadelle Liège — Recruiting
Contact information
- Noor Benmhammed
43217726 ext. +32
Noor.Benmhammed@citadelle.be - Tamara Dangouloff, PhD
tamara.dangouloff@uliege.be
Full registry eligibility criteria
Inclusion Criteria: * Genetically confirmed diagnosis of AS * 0-99 years * Male or Female * Participant's carer is willing to give IC/sign a "record of consultation" for participation in the study Exclusion Criteria: * comorbidity that could potentially affect the results of the study coexists. This
Important information
Registry information may change. FAST context and classifications are editorial additions. Inclusion does not confirm eligibility or availability at a specific site. Review the official record and contact the study team for participation requirements.